Overview of Medicare Part D prescription drug benefit: Potential implications for patients with psychotic disorders

被引:1
|
作者
Rosenberg, Jack A.
机构
[1] Long Isl Univ, Int Drug Informat Ctr, Brooklyn, NY 11201 USA
[2] Long Isl Univ, Arnold & Marie Schwartz Coll Pharm & Hlth Sci, Brooklyn, NY 11201 USA
关键词
costs; economics; healthbenefit programs; laws; pharmacists; prescriptions; psychotherapeutic agents; psychotic disorders;
D O I
10.2146/ajhp060592
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose. Medicare Part D prescription drug benefits are reviewed. Potential implications, for patients with psychotic disorders in relation to Medicare Part D are discussed. Summary. The newly created Medicare Part D provides prescription drug benefits to many individuals formerly without prescription benefits and, possibly, lower-cost benefits to those who previously relied on other benefits., Participating prescription plans use a variety of pharmacy management tools to minimize costs while providing benefit plans that meet Part D requirements for composition and coverage. Patients then have the challenge of choosing a prescription drug plan that will best satisfy their prescriptions needs. Conclusion. The rollout of Part D has not been without problems, and although more Medicare participants are receiving prescription drug benefits at a greater savings,there are concerns that Part D may not provide adequate coverage for all patients or for patients requiring certain types of medications, especially some psychotropic medications. Pharmacists have voiced concerns about the Medicare Part D drug plan in regard to both the degree of coverage it provides to enrollees and the difficulty in administering the benefit.
引用
收藏
页码:S18 / S23
页数:6
相关论文
共 50 条